by Canton & Company | Mar 11, 2021
Despite the global pandemic, 2020 deal activity flourished among private equity (PE) investors in healthcare. The market’s resilience during economic downturns has made it particularly attractive to PE firms, especially those with substantial amounts of dry powder....
by Canton & Company | Mar 4, 2021
Companies operating in the healthcare space often see their growth curves plateau at some point. In recent years, many have found that partnering with private equity (PE) is the best way to launch a new phase for their businesses, providing revenue opportunities as...
by Canton & Company | Feb 24, 2021
Healthcare is a resilient industry, and private equity (PE) has taken notice. As firms scour the market searching for attractive assets to add to their portfolios, PE investors have refined their targeting strategies. Specialization among PE firms has intensified....
by Canton & Company | Feb 16, 2021
The number of private equity (PE) investment firms has grown over the past decade, and those investors have become quite active in the healthcare sector. And with good reason. Healthcare offers the right mix of opportunity and resilience that attracts PE interest....
